CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE1600.0054.55 (+3.53 %)
PREV CLOSE () 1545.45
OPEN PRICE () 1527.05
BID PRICE (QTY) 1600.00 (57)
OFFER PRICE (QTY) 1602.90 (26)
VOLUME 34489
TODAY'S LOW / HIGH ()1527.05 1624.00
52 WK LOW / HIGH ()1075 1924
NSE1587.0045.1 (+2.92 %)
PREV CLOSE() 1541.90
OPEN PRICE () 1548.10
BID PRICE (QTY) 1586.00 (25)
OFFER PRICE (QTY) 1587.00 (67)
VOLUME 870426
TODAY'S LOW / HIGH() 1530.00 1624.70
52 WK LOW / HIGH ()1057 1925
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2007

Management Info :

Arun Kumar - Chairman Neeraj Sharma - Managing Director

Registered Office :

Address : Unit No. 902, Cyber One,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone : 022 2789 2924

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
21Jul Onesource Specialty Pharma submits ana
Onesource Specialty Pharma has informed that the Company has scheduled i..
14Jul OneSource Specialty Pharma, Formycon p
OneSource Specialty Pharma has entered into a strategic manufacturing pa..
14Jul OneSource Specialty Pharma informs ab
OneSource Specialty Pharma has informed that it enclosed Press Release i..
02Jul USFDA completes cGMP inspection at One
The United States Food and Drug Administration (USFDA) has conducted a r..
16May Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed that the Government of Karnataka..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit512.25212.1
Gross Profit 512.25 212.1
Operating Profit 1179.192840.01
Net Sales 4464.7114053.81
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25530.00 (1.02%)
M.Cap ( in Cr)
54249.47
Torrent Pharma (BSE)
 4975.10 (0.95%)
M.Cap ( in Cr)
189012.40
SMS Pharmaceuticals (BSE)
 461.55 (10.12%)
M.Cap ( in Cr)
4336.09
Laurus Labs (BSE)
 1971.35 (1.83%)
M.Cap ( in Cr)
106441.51
Rubicon Research (BSE)
 1824.75 (1.91%)
M.Cap ( in Cr)
29605.38
Shareholding Pattern
PROMOTERS 30.48%
NON-INSTITUTION 26.94%
MUTUAL FUNDS/UTI 12.98%
FI/BANKS/INSURANCE 2.86%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74790.49-112.10 (-0.15%)
NIFTY23422.75-55.05 (-0.23%)
Dow Jones 52064.10-316.56 (-0.60%)
Nasdaq 26081.72-171.62 (-0.65%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI